Regulatory Challenges for Cell-Based Therapies

Here, both Dr. Verdun and Dr. Marks provide detailed feedback on the regulatory challenges facing cell therapy. They explain the Agency’s most important focal points for 2024, patient accessibility, and more.

Check out the full digital event available on-demand thanks to the support of Thermo Fisher Scientific Bioproduction - https://www.cellandgene.com/doc/regul...

• #science_technology
• #cell_gene_live
• #thermo_fisher_scientific
• #cell_therapy
• #fda
• #regulatory_affairs
• #autologous_cell_therapy
• #allogeneic_cell_therapy